Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y. Ng, Raphael Koch, Noriaki Yoshida et al.|Nature Communications|2018Cited by 114
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomasRaphael Koch, David M. Weinstock, Deborah Plana et al.|Blood|2018Cited by 63